Publications
- Therapeutic potential and limitations of curcumin as antimetastatic agent2023 | First Faculty of Medicine
- Epigenetic agents in combined anticancer therapy2018 | First Faculty of Medicine
- Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapyPublication without faculty affiliation
- Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication2023 | First Faculty of Medicine
- TET protein inhibitors: Potential and limitations2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Chelators as Antineuroblastomas Agents2023 | First Faculty of Medicine
- Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration2022 | First Faculty of Medicine, Faculty of Science
- Non-psychotropic cannabinoids as inhibitors of TET1 protein2022 | First Faculty of Medicine
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
Loading network view...